| Aspire Pharmaceuticals, Inc. | Division of Human and Animal Food Operations East II | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
Friday, April 7, 2023
Friday, March 31, 2023
This week, the FDA approved three first-time generic animal drugs, bringing additional options to the table for veterinarians, pet owners and animal producers:
On Wednesday, the FDA approved Modulis for Cats, the first generic cyclosporine oral solution for cats. Modulis for Cats is indicated for the control of certain skin conditions resulting from a disease called feline allergic dermatitis.
On Thursday, the FDA approved Tauramox, the first generic moxidectin injectable solution indicated for beef and nonlactating dairy cattle for the treatment and control of internal and external parasites in cattle.
Today, the FDA approved the first generic Maropitant Citrate tablets for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
Wednesday, March 29, 2023
Gipsco Investment Corp. (dba Lee Silsby Compounding Pharmacy), Cleveland Heights, OH - 503A Facility
- FMD-145 Issued 1/6/2023
First Royal Care Co. LLC, (dba Red Mountain Compounding Pharmacy), Mesa, AZ - 503A Facility
- FMD-145 Letter Issued 2/13/2023
Subscribe to:
Posts (Atom)